Outcomes of stereotactic body radiotherapy 60 Gy in 8 fractions when prioritizing organs at risk for central and ultracentral lung tumors

BACKGROUND: For stereotactic body radiotherapy (SBRT) to central (C) and ultracentral (UC) lung tumors, our provincial practice has been to prioritize organs at risk (OARs) constraints by compromising target volume coverage if needed. The objectives are to report the treatment’s efficacy and safety....

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yizhou, Khawandanh, Eman, Thomas, Steven, Zhang, Susan, Dunne, Emma M., Liu, Mitchell, Schellenberg, Devin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047404/
https://www.ncbi.nlm.nih.gov/pubmed/32106868
http://dx.doi.org/10.1186/s13014-020-01491-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047404/
https://www.ncbi.nlm.nih.gov/pubmed/32106868
http://dx.doi.org/10.1186/s13014-020-01491-w

Ejemplares similares